PGS

THE CASE FOR REINSURANCE

31/07/20 -"Up to COVID-19 times, Reinsurers’ fabulous ride was primarily a reflection of investors buying the best of both worlds: quality oligopoly-type businesses and self-propelled valuations, courtesy of ..."

PDF page sample
Pages
48
Language
English
Published on
31/07/20
Download
You may also be interested by these reports :
08/10/26
We raise our adjusted EPS to USD 1.17 in 2026 and USD 0.81 in 2027, from USD 0.69 and USD 0.59, while 2028 eases to USD 0.55 from USD 0.69. Our Brent ...
06/10/26
We raise our NAV from €70.2/share to €83.9/share. The uplift is primarily driven by our revised commodity price deck. Brent increases to $91.5/bbl in ...
02/10/26
The closure of the Strait of Hormuz in the US-Iran conflict and Ukrainian strikes on Russian refineries have cut diesel supply. Europe, short of ...
28/09/26
This CMD extends TotalEnergies’ horizon without speeding up its growth. The 2030 targets are confirmed as they stood, and the post-2030 outlook ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO